The platelet-to-lymphocyte ratio (PLR) has emerged as an informative marker revealing
shifts in platelet and lymphocyte counts due to acute inflammatory and prothrombotic states …

Risk prediction of chemotherapy-associated venous thromboembolism (VTE) is a
compelling challenge in contemporary oncology, as VTE may result in treatment delays …

Patients with cancer are at risk of developing venous and arterial thromboembolism (VTE
and ATE). Elevated platelet-to-lymphocyte (PLR) and neutrophil-to-lymphocyte ratios (NLR) …

Objective Deep venous thrombosis (DVT) is associated with a state of increased
inflammation at the time of diagnosis as either a cause or consequence. The neutrophil …

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of cancer and has a poor
prognosis. Patients with PDAC are at high risk of developing thromboembolic events, which …

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and
pulmonary embolism (PE), has been an important cause of sudden in-hospital death …

Objective To assess the incidence of vascular events in patients with head and neck cancer.
Review Methods Primary studies identified through April 2023. Meta‐analysis was …

Background Pulmonary thromboembolism (PTE) is a common complication of severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which raises the COVID‐19 disease's …

Background: Glioma is the most common and deadliest malignant primary intracranial brain
tumor in adults. It remains unclear whether the pre-treatment peripheral blood test …

Purpose To analyze and stratify the possible risk factors of venous thromboembolism (VTE)
in lateral skull base surgery (LSBS) using the Caprini risk assessment model. Methods In a …